Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken

Commercial inactivated vaccines against H9N2 avian influenza (AI) have been developed in China since 1990s and show excellent immunogenicity with strong HI antibodies. However, currently approved vaccines cannot meet the clinical demand for a live-vectored vaccine. Newcastle disease virus (NDV) vect...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenhao, Dai, Jing, Liu, Jingjing, Guo, Mengjiao, Liu, Xiaowen, Hu, Shunlin, Gu, Min, Hu, Jiao, Hu, Zenglei, Gao, Ruyi, Liu, Kaituo, Chen, Yu, Liu, Xiufan, Wang, Xiaoquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144924/
https://www.ncbi.nlm.nih.gov/pubmed/35632659
http://dx.doi.org/10.3390/v14050918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144924/
https://www.ncbi.nlm.nih.gov/pubmed/35632659
http://dx.doi.org/10.3390/v14050918

Ejemplares similares